期刊文献+

氨甲环酸用于非体外循环冠状动脉搭桥术血液保护作用的Meta分析 被引量:3

The Blood Preservation Effect of Tranexamic Acid in Off-pump Coronary Bypass Graft Surgery: A Meta-analysis
原文传递
导出
摘要 目的采用系统回顾和Meta分析评价氨甲环酸用于非体外循环冠状动脉搭桥术(OPCAB)的血液保护效果及安全性。方法全面检索Pubmed、CochraneCENTRAL、EMBASE数据库,将行OPCAB术患者,分为氨甲环酸组和对照组进行比较,报道了至少一项明确临床结果的所有随机临床试验均纳入本Meta分析,日期截止至2012年1月。使用ReviewManager5.1统计学软件行Meta分析,计数资料计算优势比(OR)和95%可信区间(CI),连续变量计算加权均数差(WMD)和95%CI。结果共10项随机临床试验中的849例病人纳入该Meta分析。在OPCAB术中,同对照组相比,氨甲环酸可明显减少病人24h的胸腔引流量(WMD-209ml,95%CI:-310ml^-107ml,p<0.001),并显著降低异体红细胞(OR0.46,95%CI:0.33~0.63,p<0.001)和新鲜冰冻血浆(OR0.30,95%CI:0.18~0.51,p<0.001)的使用率。两组病人术后严重栓塞并发症(包括急性心肌梗死、中风和肺栓塞)和肾功能衰竭的发生率,以及ICU停留时间、住院时间均无显著差别。结论现有证据表明OPCAB术应用氨甲环酸可减少术后出血量,减低异体血使用率,有明确的血液保护作用。 Objective To determine the blood preservation efficacy and safety oftranexamic acid for off-pump coronary bypass graft (OPCAB) surgery by systematic review and meta-analysis. Methods A comprehensive search was undertaken to identify all randomized trials of tranexamic acid in OPCAB surgery. Pubmed, Cochrane CENTRAL and EMBASE databases were searched up to January 2012. All randomized trials comparing tranexamic acid and placebo in OPCAB surgery and reporting at least one predefined clinical outcome were included. Meta-analysis was conducted using the Cochrane Collaboration' s Revman 5.1 software. The odd radio (OR and confidence intervals [CI]) and weighted mean differences (WMD, 95% CI) were calculated for dichotomous and continuous vaviables, respectively. Results Ten randomized trials involving 849 patients were included in the meta-analysis. During OPCAB surgery, the use of tranexamic acid significantly decreased the 24h chest-tube drainage (WMD -209ml, 95%CI : -310ml- -107ml, p〈0.001) and reduced the transfusion rate of allogeneic red blood cells (OR 0.46, 95%CI : 0.33 - 0.63, p〈0.001) and fresh frozen plasma (OR 0.30, 95%CI : 0.18 -0.51, p〈 0.001). There was no difference in severe thromboembolic complications (myocardial infarction, stroke and pulmonary embolism) and renal failure, ICU stay and hospital stay between tranexamic acid and placebo groups. Conclusions Current evidence suggests that tranexamic acid reduces the blood loss and the exposure to aUogeneic blood products in OPCAB surgery, has blood conservation effect.
出处 《中国分子心脏病学杂志》 CAS 2013年第1期398-401,共4页 Molecular Cardiology of China
关键词 氨甲环酸 冠状动脉旁路移植术 不停跳 术后出血 输血 META分析 Tranexamic acid Coronary artery bypass off-pump Postoperative hemorrhage Blood transfusion Meta-analysis
  • 相关文献

参考文献19

  • 1Biglioli P, Cannata A, Alamanni F, et al. Biological effects of off- pump vs. On-pump coronary artery surgery: Focus on inflammation, hemostasis and oxidative stress. Eur J Cardiothorac Surg. 2003, 24(2): 260-269.
  • 2AI-Ruzzeh S, George S, Bustami M, et al. Effect of off-pump coronary artery bypass surgery on clinical, angiographic, neurocognitive, and quality of life outcomes: Randomised controlled trial. BMJ. 2006, 332(7554): 1365-1371.
  • 3Henry D, Carless P, Fergusson D, et al. The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: A meta-analysis. CMAJ : Canadian Medical Association journal. 2009, 180(2): 183-193.
  • 4Ahn SW, Shim JK, Youn YN, et al. Effect of tranexamic acid on transfusion requirement in dual antiplatelet-treated anemic patients undergoing off-pump coronary artery bypass graft surgery. Circulation Journal. 2012, 76(1): 96-101.
  • 5Casati V, Gerli C, Franco A, et al. Tranexamic acid in off-pump coronary surgery: A preliminary, randomized, double-blind, placebo-controlled study. Ann Thorac Surg. 2001, 72(2): 470-475.
  • 6Casati V, Della Valle P, Benussi S, et al. Effects of tranexamic acid on postoperative bleeding and related hematochemieal variables in coronarysurgery: Comparison between on-pump and off-pump techniques. The Journal of Thoracic and Cardiovascular Surgery. 2004, 128(1 ): 83-91.
  • 7Jares M, Vanek T, Straka Z, et al. Tranexamic acid reduces bleeding al:er off-pump coronary artery bypass grai:ing. J Cardiovasc Surg (Torino). 2003, 44(2): 205-208.
  • 8Mehr-Aein A Sadeghi M, Madani-civi M. Does tranexamic acid reduce blood loss in off-pump coronary artery bypass?. Asian Cardiovasc Thorac Ann. 2007, 15(4): 285-289.
  • 9Murphy G J, Mango E, Lucchetti V, et al. A randomized trial of tranexamic acid in combination with cell salvage plus a meta-analysis of randomized trials evaluating tranexamic acid in off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2006, 132(3): 475- 480, 480 e471-478.
  • 10Taghaddomi RJ, Mirzaee A, Attar AS, et al. Tranexamic acid reduces blood loss in off-pump coronary artery bypass surgery. Journal of Cardiothoracic and Vascular Anesthesia. 2009, 23(3): 312-315.

同被引文献70

  • 1Hartmann M, Sucker C, Boehm O, et al. Effects of cardiac surgery on hemostasis . TransJusion medicine reviews, 2006, 20(3): 230-241.
  • 2Murphy G J, Reeves BC, Rogers CA, et al. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation, 2007, 116(22): 2544- 2552.
  • 3Reeves BC, Murphy GJ. Increased mortality, morbidity, and cost associated with red blood cell transfusion after cardiac surgery. Current opinion in cardiology, 2008, 23(6): 607-612.
  • 4Ferraris VA, Brown JR, Despotis GJ, et al. 2011 update to the society of thoracic surgeons and the society of cardiovascular anesthesiologists blood conservation clinical practice guidelines. The Annals of thoracic surgery, 2011, 91(3): 944-982.
  • 5Sedrakyan A, Treasure T, Elefteriades JA. Effect of aprotininon clinical outcomes in coronary artery bypass graft surgery: A systematic review and meta-analysis of randomized clinical trials. The Journal of thoracic and cardiovascular surgery, 2004, 128(3): 442-448.
  • 6Henry DA, Carless PA, Moxey A J, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev, 2007, (4): CD001886.
  • 7Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med, 2006, 354(4): 353- 365.
  • 8Brown JR, Birkmeyer NJO, O'Connor GT. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery. Circulation, 2007, 115(22): 2801-2813.
  • 9Fergusson DA, Hebert PC, Mazer CD, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl JMed, 2008, 358(22): 2319-2331.
  • 10Mangano DT, Miao Y, Vuylsteke A, et al. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA : the journal of the American Medical Association, 2007, 297(5): 471-479.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部